Next Article in Journal
Preferential Incorporation of Azelaic Acid Units into the Crystalline Phase of the Copoly(Alkylene Dicarboxylate) Derived from 1,9-Nonanediol and an Equimolar Mixture of Pimelic and Azelaic Acids
Next Article in Special Issue
Comparative Efficacies of a 3D-Printed PCL/PLGA/β-TCP Membrane and a Titanium Membrane for Guided Bone Regeneration in Beagle Dogs
Previous Article in Journal
Biocatalytic Self-Cleaning Polymer Membranes
Previous Article in Special Issue
Conjugation of ß-Adrenergic Antagonist Alprenolol to Implantable Polymer-Aescin Matrices for Local Delivery
Article Menu

Export Article

Open AccessArticle
Polymers 2015, 7(9), 1850-1870;

Preparation and Evaluation of Vancomycin-Loaded N-trimethyl Chitosan Nanoparticles

Department of Medicine, Wenzhou Medical University, Wenzhou 325000, China
Zhejiang Pharmaceutical College, Ningbo 315000, China
Department of Medicine, Zhejiang Academy of Traditional Chinese Medicine, Hangzhou 310000, China
These authors contributed equally to this work.
Author to whom correspondence should be addressed.
Academic Editor: Jianxun Ding
Received: 14 July 2015 / Revised: 23 August 2015 / Accepted: 6 September 2015 / Published: 22 September 2015
(This article belongs to the Special Issue Functional Polymers for Medical Applications)
Full-Text   |   PDF [3487 KB, uploaded 22 September 2015]   |  


Chronic intracellular infections caused by drug-resistant pathogens pose a challenge to the treatment of chronic osteomyelitis. Such treatment requires an intracellular delivery system for the sustained release of antibiotics such as vancomycin (VCM), which is an antibiotic of last resort used against many clinically resistant bacteria. In this work, we report VCM-loaded N-trimethyl chitosan (TMC) nanoparticles and their potential application for drug delivery. The results showed that the prepared nanoparticles were predominantly spherical in shape with an average particle diameter of 220 nm, a positive zeta potential, and a loading efficiency of 73.65% ± 1.83%. Furthermore, their drug release profile followed the Higuchi model for sustained release, with non-Fickian diffusion. Over a 24-h period, 6.51% ± 0.58% of the drug within the optimized nanoparticles was released. In vitro cytology showed that osteoblasts (OBs) exhibited higher alkaline phosphatase activity (ALP) after exposure to TMC nanoparticle material. Furthermore, TMC nanoparticles increased the uptake of water-soluble quantum dots (QDs) by OBs, and both nanoparticles and VCM/TMC mixtures improved OB proliferative activity. We also investigated the minimum inhibitory concentration (MIC, 60 μg/mL), half maximal inhibitory concentration (IC50, 48.47 μg/mL), diameter of inhibition zone (DIZ, 1.050 cm), and turbidimetric (TB) assay of nanoparticles. All data demonstrated that VCM/TMC nanoparticles had excellent antibacterial activity against the Gram-positive bacterium Staphylococcus aureus. These findings suggest that VCM-loaded TMC nanoparticles have good potential for the sustained delivery of antibiotics to bone infections. View Full-Text
Keywords: vancomycin (VCM); N-trimethyl chitosan (TMC); intracellular infections; nanoparticles vancomycin (VCM); N-trimethyl chitosan (TMC); intracellular infections; nanoparticles

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Xu, J.; Xu, B.; Shou, D.; Xia, X.; Hu, Y. Preparation and Evaluation of Vancomycin-Loaded N-trimethyl Chitosan Nanoparticles. Polymers 2015, 7, 1850-1870.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Polymers EISSN 2073-4360 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top